Trial intelligence / Profile preview

ACM-001.1 and Pindolol in Healthy Volunteers

NCT06028321Phase 1Completed

Sponsor
Actimed Therapeutics
Start
Nov 2021
Primary completion
Jun 2022
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of s-pindolol benzoate in cachexia (7 arms), sponsored by Actimed Therapeutics. Started Nov 2021; status: completed.

02

Drugs

s-pindolol benzoate
03

Conditions

cachexia

Beyond the preview

Go deeper on NCT06028321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06028321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call